Curcumin promotes the hepatocytes-uptake of plasma LDLC by down-regulating IDOL level
Author:
Affiliation:

1.Department of Biochemistry & Molecular Biology, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, China;2.Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China;3.Department of Metabolic Endocrinology, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong 518110, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [32]
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Aim To explore the effect of Curcumin on that inducible degrader of the low density lipoprotein receptor (IDOL) regulating the uptake of low density lipoprotein cholesterol (LDLC) of hepatocytes. Methods HepG2 and LO2 cells (two kinds of hepatocytes) were infected with the constructed overexpression or RNA-interference IDOL (OE/RNAi-IDOL) lentivirus. The efficiency of the lentiviral infection experiment was evaluated by fluorescence microscopy. The expression of IDOL and low density lipoprotein receptor (LDLR) proteins was detected by Western blot. After HepG2 and LO2 cells were treated with Curcumin for 24 hours, intracellular lipid droplets were determined by red oil O staining; cholesterol content was detected by using cholesterol testing kits; the uptake of LDLC by hepatocytes was detected by DiI-LDL uptake experiment; LDLR abundances of hepatocytes surfaces were determined by immune flow cytometry. Results Compared with white light view, the phenomenon of the green fluorescence was observed both in HepG2 and LO2 cells infected by OE-IDOL and RNAi-IDOL lentivirus; Western blot results showed that both in HepG2 and LO2 cells infected by RNAi-IDOL-2 lentivirus, IDOL protein expression were decreased, while LDLR expression was increased (P<0.01); on the contrary, in HepG2 and LO2 cells infected by OE-IDOL lentivirus, IDOL protein expression was increased, while LDLR expression was decreased, the above results indicated that both HepG2 and LO2 cells infected by OE/RNAi-IDOL lentivirus had been acquired. Compared with the control group of HepG2 and LO2 cells without any treatment, after 25 μmol/L Curcumin treatment for 24 hours in the OE/RNAi-IDOL lentivirus infected cells, both the intracellular lipid droplet content and relative cholesterol content were increased in the treatment group (P<0.01), meanwhile the uptake LDLC ability and cell surface LDLR abundances of hepatocytes were also enhanced (P<0.01), the same trend was also observed in the results of Rosuvastatin treatment group. Conclusion The levels of IDOL protein in liver cells were down-regulated by Curcumin, which further promotes the uptake of LDLC of liver cells.

    Reference
    [1] DONG Z, JING L, MIAO W, et al.Epidemiology of cardiovascular disease in China:current features and implications.Nat Rev Cardiol, 9,6(4):203-212.
    [2] MACH F, BAIGENT C, CATAPANO A L, et al.2019 ESC/EAS guidelines for themanagement of dyslipidaemias:lipid modification to reduce cardiovascular risk.Eur Heart J, 0,1(1):111-188.
    [3] ISTVAN E S, DEISENHOFER J.Structural mechanism for statin inhibition of HMG-CoA reductase.Science, 1,2(5519):1160-1164.
    [4] SIMIC I, REINER Z.Adverse effects of statins-myths and reality.Curr Pharm Des, 5,1:1220-1226.
    [5] CHASMAN D, GIULIANINI F, MACFADYEN J, et al.Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction:the justification for the use of statins in prevention:an intervention trial evaluating rosuvastatin (Jupiter) trial.Circ Cardiovasc Genet, 2,5(2):257-264.
    [6] TURNER R M, PIRMOHAMED M.Statin-related myotoxicity:a comprehensive review of pharmacokinetic, pharmacogenomic and muscle components.J Clin Med, 9,9(1):22.
    [7] BOUITBIR J, SANVEE G M, PANAJATOVIC M V, et al.Mechanisms of statin-associated skeletal muscle-associated symptoms.Pharmacol Res, 0,4:104201.
    [8] GOEL A, KUNNUMAKKARA A B, AGGARWAL B B, et al.From kitchen to clinic.Biochem Pharmacol, 8,5:787-809.
    [9] ESMAILY H, SAHEBKAR A, IRANSHAHI M, et al.An investigation of the effects of curcumin on anxiety and depression in obese individuals:a randomized controlled trial.Chin J Integr Med, 5,1(5):332-338.
    [10] PANAHI Y, HOSSEINI M S, KHALILI N, et al.Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome:a randomized controlled trial and an updated Meta-analysis.Clin Nutr, 5,4(6):1101-1108.
    [11] SAHEBKAR A.Curcuminoids for the management of hypertriglyceridaemia.Nat Rev Cardiol, 4,1(2):123.
    [12] TAKEMOTO M, LIAO J K.Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.Arterioscler Thromb Vasc Biol, 1,1(11):1712-1719.
    [13] CALKIN A C, GOULT B T, ZHANG L, et al.FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors.Proc Natl Acad Sci U S A, 1,8(50):20107-20112.
    [14] SORRENTINO V, ZELCER N.Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.Curr Opin Lipidol, 2,3(3):213-219.
    [15] 王楚瑶, 蒋素素, 向德彪, 等.姜黄素通过调节PCSK9促进肝细胞摄取血浆LDL-C.中国药理学通报, 0,6(10):1415-1421.
    [16] CAI Y, LU D, ZOU Y, et al.Curcumin protects against intestinal origin endotoxemia in rat liver cirrhosis by targeting PCSK9.J Food Sci, 7,2(3):772-780.
    [17] TAI M H, CHEN P K, CHEN P Y, et al.Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells.Mol Nutr Food Res, 4,8(11):2133-2145.
    [18] VEGA G L, GRUNDY S M.Current trends in non-HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease.J Clin Lipidol, 9,3(4):563-567.
    [19] FERENCE B A, GINSBERG H N, GRAHAM I, et al.Low-density lipoproteins cause atherosclerotic cardiovascular disease.1.Evidence from genetic, epidemiologic, and clinical studies.A consensus statement from the European Atherosclerosis Society Consensus Panel.Eur Heart J, 7,8(32):2459-2472.
    [20] GRUNDY S M, STONE N J, BAILEY A L, et al.2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol:a report of the American college of cardiology/American heart association task force on clinical practice guidelines.Circulation, 9,9(25):e1082-e1143.
    [21] KAPUR N K, MUSUNURU K.Clinical efficacy and safety of statins in managing cardiovascular risk.Vasc Health Risk Manag, 8,4(2):341-353.
    [22] TARN D M, PLETCHER M J, TOSQUI R, et al.Primary nonadherence to statin medications:survey of patient perspectives.Prev Med Rep, 1,2:101357.
    [23] GRAVERSEN C B, LARSEN M L, SCHMIDT E B.Statin intolerance.Ugeskr Laeger, 5,7(36):V03150271.
    [24] JEON H, BLACKLOW S C.Structure and physiologic function of the low-density lipoprotein receptor.Annu Rev Biochem, 5,4:535-562.
    [25] RADHAKRISHNAN A, GOLDSTEIN J L, MCDONALD J G, et al.Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol:a delicate balance.Cell Metab, 8,8(6):512-521.
    [26] 周音频, 宁琳, 向立权, 等.姜黄素增强脂多糖跨膜转运的机制及其抗动脉粥样硬化作用.中国老年学杂志, 7,7(7):1617-1619.
    [27] NABAVI S F, DAGLIA M, MOGHADDAM A H, et al.Curcumin and liver disease:from chemistry to medicine.Compr Rev Food Sci Food Saf, 4,3(1):62-77.
    [28] LV Y L, JIA Y, WAN Z, et al.Curcumin inhibits the formation of atherosclerosis in ApoE-/- mice by suppressing cytomegalovirus activity in endothelial cells.Life Sci, 0,7:117658.
    [29] MAJEED M L, GHAFIL F A, FATIMA G, et al.Anti-atherosclerotic and anti-inflammatory effects of curcumin on hypercholesterolemic male rabbits.Indian J Clin Biochem, 1,6(1):74-80.
    [30] 欧露, 张彩平, 刘英, 等.PCSK9及IDOL在姜黄素促进HepG2细胞摄取LDL-C中的作用.中国药理学通报, 5,1(9):1286-1291.
    [31] 程静屏, 阳学风.姜黄素对人肝LO2细胞胆固醇合成及转运蛋白表达的影响.湖北中医药大学学报, 1,3(3):6-11.
    [32] 滕耀红, 祝骥, 庞珍珍, 等.姜黄素对非酒精性脂肪肝细胞胆固醇代谢的影响.浙江中医药大学学报, 4,8(2):115-120.
    Related
    Cited by
Get Citation

JIANG Susu, ZENG Yalin, NING Jie, SHAO Jingqi, YUAN Yulin, ZHAO Qian, YUAN Lingzhi, LONG Shiyin, ZHANG Caiping, LIAO Duanfang. Curcumin promotes the hepatocytes-uptake of plasma LDLC by down-regulating IDOL level[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2021,29(9):751-760.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:November 07,2020
  • Revised:January 18,2021
  • Online: August 10,2021
Article QR Code